1. Home
  2. TLSI vs PWOD Comparison

TLSI vs PWOD Comparison

Compare TLSI & PWOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLSI
  • PWOD
  • Stock Information
  • Founded
  • TLSI 2010
  • PWOD 1934
  • Country
  • TLSI United States
  • PWOD United States
  • Employees
  • TLSI N/A
  • PWOD N/A
  • Industry
  • TLSI Medical Specialities
  • PWOD Major Banks
  • Sector
  • TLSI Health Care
  • PWOD Finance
  • Exchange
  • TLSI Nasdaq
  • PWOD Nasdaq
  • Market Cap
  • TLSI 124.9M
  • PWOD 227.1M
  • IPO Year
  • TLSI N/A
  • PWOD N/A
  • Fundamental
  • Price
  • TLSI $4.69
  • PWOD $29.93
  • Analyst Decision
  • TLSI Strong Buy
  • PWOD
  • Analyst Count
  • TLSI 6
  • PWOD 0
  • Target Price
  • TLSI $11.75
  • PWOD N/A
  • AVG Volume (30 Days)
  • TLSI 36.4K
  • PWOD 25.1K
  • Earning Date
  • TLSI 11-14-2024
  • PWOD 01-27-2025
  • Dividend Yield
  • TLSI N/A
  • PWOD 4.32%
  • EPS Growth
  • TLSI N/A
  • PWOD 20.90
  • EPS
  • TLSI N/A
  • PWOD 2.62
  • Revenue
  • TLSI $26,891,000.00
  • PWOD $67,724,000.00
  • Revenue This Year
  • TLSI $60.96
  • PWOD N/A
  • Revenue Next Year
  • TLSI $53.65
  • PWOD N/A
  • P/E Ratio
  • TLSI N/A
  • PWOD $11.18
  • Revenue Growth
  • TLSI 67.90
  • PWOD 5.88
  • 52 Week Low
  • TLSI $3.50
  • PWOD $17.01
  • 52 Week High
  • TLSI $10.42
  • PWOD $34.56
  • Technical
  • Relative Strength Index (RSI)
  • TLSI 51.68
  • PWOD 45.65
  • Support Level
  • TLSI $4.72
  • PWOD $28.69
  • Resistance Level
  • TLSI $5.32
  • PWOD $30.99
  • Average True Range (ATR)
  • TLSI 0.31
  • PWOD 0.78
  • MACD
  • TLSI 0.01
  • PWOD -0.20
  • Stochastic Oscillator
  • TLSI 47.52
  • PWOD 37.46

About TLSI TriSalus Life Sciences Inc.

TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.

About PWOD Penns Woods Bancorp Inc.

Penns Woods Bancorp Inc is the bank holding company for Jersey Shore State Bank and Luzerne Bank. The banks serve customers in North Central and North Eastern Pennsylvania through their retail banking, commercial banking, mortgage services and financial services divisions. The Banks are engaged in commercial and retail banking which includes the acceptance of time, savings, and demand deposits, the funding of commercial, consumer, and mortgage loans, and safe deposit services. Utilizing a branch office network, ATMs, Internet, and telephone banking delivery channels, the Banks deliver their products and services to the communities residing in.

Share on Social Networks: